These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 20541540

  • 21. Liver-specific enhancer in ABCC6 promoter-Functional evidence from natural polymorphisms.
    Ratajewski M, de Boussac H, Pulaski L.
    Biochem Biophys Res Commun; 2009 May 22; 383(1):73-7. PubMed ID: 19341707
    [Abstract] [Full Text] [Related]

  • 22. Arterial remodeling and stiffness in patients with pseudoxanthoma elasticum.
    Germain DP, Boutouyrie P, Laloux B, Laurent S.
    Arterioscler Thromb Vasc Biol; 2003 May 01; 23(5):836-41. PubMed ID: 12649085
    [Abstract] [Full Text] [Related]

  • 23. Analysis of sequence variations in the ABCC6 gene among patients with abdominal aortic aneurysm and pseudoxanthoma elasticum.
    Schulz V, Hendig D, Schillinger M, Exner M, Domanovits H, Raith M, Szliska C, Kleesiek K, Gotting C.
    J Vasc Res; 2005 May 01; 42(5):424-32. PubMed ID: 16127278
    [Abstract] [Full Text] [Related]

  • 24. New ABCC6 gene mutations in German pseudoxanthoma elasticum patients.
    Hendig D, Schulz V, Eichgrün J, Szliska C, Götting C, Kleesiek K.
    J Mol Med (Berl); 2005 Feb 01; 83(2):140-7. PubMed ID: 15723264
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Heterozygous carriers of Pseudoxanthoma elasticum were not found among patients with cervical artery dissections.
    Morcher M, Hausser I, Brandt T, Grond-Ginsbach C.
    J Neurol; 2003 Aug 01; 250(8):983-6. PubMed ID: 12928920
    [Abstract] [Full Text] [Related]

  • 28. Patients with premature coronary artery disease who carry the ABCC6 R1141X mutation have no Pseudoxanthoma Elasticum phenotype.
    Wegman JJ, Hu X, Tan H, Bergen AA, Trip MD, Kastelein JJ, Smulders YM.
    Int J Cardiol; 2005 Apr 28; 100(3):389-93. PubMed ID: 15837081
    [Abstract] [Full Text] [Related]

  • 29. Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum.
    Hendig D, Schulz V, Arndt M, Szliska C, Kleesiek K, Götting C.
    Clin Chem; 2006 Feb 28; 52(2):227-34. PubMed ID: 16384891
    [Abstract] [Full Text] [Related]

  • 30. SPP1 promoter polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum.
    Hendig D, Arndt M, Szliska C, Kleesiek K, Götting C.
    Clin Chem; 2007 May 28; 53(5):829-36. PubMed ID: 17384004
    [Abstract] [Full Text] [Related]

  • 31. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
    Zhou G, Zhai Y, Cui Y, Qiu W, Yang H, Zhang X, Dong X, He Y, Yao K, Zhang H, Peng Y, Yuan X, Zhi L, Zhang X, He F.
    Hum Mutat; 2007 Nov 28; 28(11):1091-7. PubMed ID: 17607721
    [Abstract] [Full Text] [Related]

  • 32. Polymorphisms in the xylosyltransferase genes cause higher serum XT-I activity in patients with pseudoxanthoma elasticum (PXE) and are involved in a severe disease course.
    Schön S, Schulz V, Prante C, Hendig D, Szliska C, Kuhn J, Kleesiek K, Götting C.
    J Med Genet; 2006 Sep 28; 43(9):745-9. PubMed ID: 16571645
    [Abstract] [Full Text] [Related]

  • 33. Extracutaneous ultrastructural alterations in pseudoxanthoma elasticum.
    Gheduzzi D, Sammarco R, Quaglino D, Bercovitch L, Terry S, Taylor W, Ronchetti IP.
    Ultrastruct Pathol; 2003 Sep 28; 27(6):375-84. PubMed ID: 14660276
    [Abstract] [Full Text] [Related]

  • 34. Novel clinico-molecular insights in pseudoxanthoma elasticum provide an efficient molecular screening method and a comprehensive diagnostic flowchart.
    Vanakker OM, Leroy BP, Coucke P, Bercovitch LG, Uitto J, Viljoen D, Terry SF, Van Acker P, Matthys D, Loeys B, De Paepe A.
    Hum Mutat; 2008 Jan 28; 29(1):205. PubMed ID: 18157818
    [Abstract] [Full Text] [Related]

  • 35. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
    O-Charoenrat P, Khantapura P.
    Oral Oncol; 2006 Mar 28; 42(3):257-67. PubMed ID: 16275157
    [Abstract] [Full Text] [Related]

  • 36. Contribution of ABCC6 genomic rearrangements to the diagnosis of pseudoxanthoma elasticum in French patients.
    Chassaing N, Martin L, Bourthoumieu S, Calvas P, Hovnanian A.
    Hum Mutat; 2007 Oct 28; 28(10):1046. PubMed ID: 17823974
    [Abstract] [Full Text] [Related]

  • 37. Identification of heterozygote carriers in families with a recessive form of pseudoxanthoma elasticum (PXE).
    Bacchelli B, Quaglino D, Gheduzzi D, Taparelli F, Boraldi F, Trolli B, Le Saux O, Boyd CD, Ronchetti IP.
    Mod Pathol; 1999 Dec 28; 12(12):1112-23. PubMed ID: 10619263
    [Abstract] [Full Text] [Related]

  • 38. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer.
    Yu C, Pan K, Xing D, Liang G, Tan W, Zhang L, Lin D.
    Cancer Res; 2002 Nov 15; 62(22):6430-3. PubMed ID: 12438229
    [Abstract] [Full Text] [Related]

  • 39. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
    Gouda HM, Khorshied MM, El Sissy MH, Shaheen IA, Mohsen MM.
    Ann Hematol; 2014 Aug 15; 93(8):1313-8. PubMed ID: 24627195
    [Abstract] [Full Text] [Related]

  • 40. Pseudoxanthoma elasticum with generalized retinal dysfunction, a common finding?
    Audo I, Vanakker OM, Smith A, Leroy BP, Robson AG, Jenkins SA, Coucke PJ, Bird AC, De Paepe A, Holder GE, Webster AR.
    Invest Ophthalmol Vis Sci; 2007 Sep 15; 48(9):4250-6. PubMed ID: 17724214
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.